Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Silarivivir potassium + sofosbuvir in chronic hepatitis C GT1b
CTR20170946Phase 2Completed
- Sponsor
- Ginkgo Tree Pharmaceutical
- Start
- Aug 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of silarivivir potassium, sofosbuvir in chronic hepatitis C (CHC), sponsored by Ginkgo Tree Pharmaceutical. Started Aug 2017; status: completed.
02
Drugs
silarivivir potassiumsofosbuvir
03
Conditions
chronic hepatitis C (CHC)
Beyond the preview
Go deeper on CTR20170946.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20170946.